Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

CMS approves Oklahoma proposal for value-based Medicaid agreements with drug manufacturers

CMS has issued an approval to Oklahoma to negotiate value-based supplemental rebate agreements directly with drug manufacturers, which could produce extra rebates for state, should clinical outcomes not be achieved.

Thumbnail

CMS policy to reduce hospital-acquired infections has minimal impact on reimbursement

New research published in Infection Control & Hospital Epidemiology suggests the 2008 CMS’ policy, Hospital Inpatient Prospective Payment System (IPPS), which penalizes hospitals for hospital-associated conditions (HAC) present at the time of the patients’ admission to the hospital has had a minimal impact on hospital reimbursement.

Medicaid benefits could be cut if work requirements aren't fixed, implemented quickly

On Friday, a federal judge denied Kentucky’s move to impose work requirements on some Medicaid recipients. Now, one Kentucky official claims benefits will be cut if this policy isn't fixed and implemented quickly.

Thumbnail

Kentucky Medicaid work requirements shot down by federal judge

Kentucky was set to become the first state in the U.S. to impose work requirements on Medicaid recipients. But a federal judge blocked the move, which was set to take effect on Sunday—claiming the Trump administration didn’t properly consider the policy’s effect on the program’s intended aim to provide medical coverage to at-risk populations.

9 accused of submitting $950M in fraudulent health insurance claims

Federal prosecutors in California announced charges against nine individuals—including orthopedic surgeons, chiropractors and a C-suite executive—for allegedly running a 15-year scheme that submitted nearly $1 billion in fraudulent health insurance claims to the federal government, California and private insurers.

Thumbnail

How will GE Healthcare fare on its own? Analysts are cautiously optimistic

GE Healthcare’s parent company has had a rough run lately. The corporate giant has lost half its value in 2017—and another 25 percent this year. GE was also delisted from the Dow Jones Industrial Average. But Monday’s news that GE would spin off its healthcare division into a separate company could provide freedom for the standalone.

Thumbnail

Wilkie opposes privatization in confirmation hearing for VA Secretary

Robert Wilkie appeared before the Senate Committee on Veterans Affairs (VA) for his confirmation hearing to be Secretary of the Department of the VA on Wednesday—three months after President Donald Trump fired then-VA Secretary David Shulkin.

Thumbnail

Zipnosis certified by Surescripts to add medication history to virtual care platform

Zipnosis, providers of virtual care software, has been certified by Surescripts to add medication history services to its virtual care platform.

Displaying 3409 - 3416 of 6655

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup